Main Article Content

Tahl Zimmerman Juan Carlos Lacal Salam A. Ibrahim

Abstract

Using chemical and artificial preservation methods to keep food safe is becoming an issue with consumers. Therefore, it is important to discover antimicrobials from natural sources for use in food safety applications. The objective of the present study was to establish screening system for natural inhibitors of choline kinase (ChoK), a known antimicrobial target. A  previously developed dual choline/phosphocholine colorimetric method was used to determine the relative strength of 3 choline kinase inhibitors: Hemocholinium-3, RSM-928A, and MN58 . Whole cell extracts containing the choline kinase of Streptococcus pneumoniae (sChoK) was used as a model.  The measured  IC50 values of these drugs were >2700 µM, 0.54 µM, and 170-225 µM, respectively. Importantly, not every step of the colorimetric method could be used in the case of every inhibitor, since each had its own particular reactive profile with the colorimetric dyes, which could have lead to confounded measurements. However, in every case, the system was flexible enough to measure choline or phosphocholine, if not both metabolites. We establish here that this dual choline/phosphocholine system is flexible enough to measure the IC50 any possible inhibitor. This colorimetric method is an ideal benchtop method for screening for natural inhibitors of bacterial ChoKs.

Article Details

References

Appleton, H. D., La Du, B. N., Jr., Levy, B., Steele, J. M., & Brodie, B. B. A chemical method for the determination of free choline in plasma. J Biol Chem, 1953, 205(2), 803-813. www.jbc.org/content/205/2/803.full.pdf

Estevez-Braun, A., Ravelo, A. G., Perez-Sacau, E., & Lacal, J. C. A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products. Clin Transl Oncol, 2015, 17(1), 74-84. https://doi.org/10.1007/s12094-014-1260-0

Grundling, A., & Schneewind, O. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(20), 8478-8483. https://doi.org/10.1073/pnas.0701821104

Gyawali, R., & Ibrahim, S. A. Impact of plant derivatives on the growth of foodborne pathogens and the functionality of probiotics. Applied Microbiology and Biotechnology, 2012, 95(1), 29-45. https://doi.org/10.1007/s00253-012-4117-x

Gyawali, R., & Ibrahim, S. A. Natural products as antimicrobial agents. Food Control, 2014, 46, 412-429. https://doi.org/10.1016/j.foodcont.2014.05.047

Hernandez-Alcoceba, R., Saniger, L., Campos, J., Nunez, M. C., Khaless, F., Gallo, M. A., Lacal, J. C. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene, 1997, 15(19), 2289-2301. https://doi.org/10.1038/sj.onc.1201414

Lacal, J. C. Choline kinase: a novel target for antitumor drugs. IDrugs : the investigational drugs journal, 2001, 4(4), 419-426. http://europepmc.org/abstract/med/16015482

Lacal Sanjuan, J. C. Choline kinase as a precision medicine target for therapy in cancer, autoimmune diseases and malaria Precision Medicine, 2015, 2(e980). https://doi.org/10.14800/pm.980

Lacal, J. C., & Campos, J. M. Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells. Molecular Cancer Therapeutics, 2015, 14(1), 31-39. https://doi.org/10.1158/1535-7163.MCT-14-0531

Tajkarimi, M. M., Ibrahim, S. A., & Cliver, D. O. Antimicrobial herb and spice compounds in food. Food Control, 2010, 21(9), 1199-1218. https://doi.org/10.1016/j.foodcont.2010.02.003

Wang, L., Jiang, Y. L., Zhang, J. R., Zhou, C. Z., & Chen, Y. X. Structural and Enzymatic Characterization of the Choline Kinase LicA from Streptococcus pneumoniae. Plos One, 2015, 10(3). https://doi.org/10.1371/journal.pone.0120467

Whiting, G. C., & Gillespie, S. H. Incorporation of choline into Streptococcus pneumoniae cell wall antigens: Evidence for choline kinase activity. Fems Microbiology Letters, 1996, 138(2-3), 141-145. https://doi.org/10.1111/j.1574-6968.1996.tb08147.x

Wittenberg, J., & Kornberg, A. Choline phosphokinase. J Biol Chem, 1953, 202(1), 431-444. http://www.jbc.org/content/202/1/431.citation

Zimmerman, T., Moneriz, C., Diez, A., Bautista, J. M., Gomez Del Pulgar, T., Cebrian, A., & Lacal, J. C. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase. Antimicrob Agents Chemother, 2013, 57(12), 5878-5888. https://doi.org/10.1128/AAC.00920-13

Zimmerman, T., & Ibrahim, S. Choline Kinase, A Novel Drug Target for the Inhibition of Streptococcus pneumoniae. Antibiotics (Basel), 2017, 6(4). https://doi.org/10.3390/antibiotics6040020

Zimmerman, T., & Ibrahim, S. A. Parallel Colorimetric Quantification of Choline and Phosphocholine as a Method for Studying Choline Kinase Activity in Complex Mixtures. Antibiotics (Basel, Switzerland), 2018, 7(1). https://doi.org/10.3390/antibiotics7010024

How to Cite
ZIMMERMAN, Tahl; LACAL, Juan Carlos; IBRAHIM, Salam A.. A dual choline/phosphocholine colorimetric method for measuring the relative strength of inhibitors of choline kinases of Gram-positive pathogens. Food Science and Applied Biotechnology, [S.l.], v. 1, n. 2, p. 131-139, oct. 2018. ISSN 2603-3380. Available at: <https://www.ijfsab.com/index.php/fsab/article/view/40>. Date accessed: 22 oct. 2018. doi: https://doi.org/10.30721/fsab2018.v1.i2.40.